Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 1, 1996, Pages 51-55

  Langford, E J ^a,b   Wainwright, R J ^a   Martin, J F ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

myocardial infarction; nitric oxide; platelets; unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; GLYCOPROTEIN; NITRIC OXIDE; PADGEM PROTEIN; S NITROSOGLUTATHIONE;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; THROMBOCYTE ACTIVATION; THROMBOGENESIS; UNSTABLE ANGINA PECTORIS;

EID: 0030060841     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.1.51     Document Type: Article

References (41)

1. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
2. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation. 1985;71:699-708.
3. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287-291.
4. Smitherman TC, Milam M, Woo J, Willerson JT, Frenkel EP. Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischacmia: direct evidence for enhanced platelet reactivity in vivo. Am J Cardiol. 1981;48:395-402.
5. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983-989.
6. Gray RP, Hendra TJ, Patterson DLH, Yudkin JS. Spontaneous platelet aggregation in whole blood in diabetic and non-diabetic survivors of acute myocardial infarction. Thromb Haemost. 1993;70: 932-936.
7. Becker RC, Tracey RP, Bovill EG, Mann KG, Ault K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. Coron Artery Dis. 1994;5:339-345.
8. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990;322:1549-1554.
9. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
10. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med. 1983;309:396-403.
11. Giles H, Smith REA, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994;24:69-72.
12. Radomski MW, Palmer RMJ, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A. 1990;87:5193-5197.
13. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2:1057-1058.
14. Mehta J, Mehta P. Comparative effect of nitroprusside and nitroglycerin on platelet aggregation in patients with heart failure. J Cardiovasc Pharmacol. 1980;2:25-33.
15. Diodati J, Theroux P, Latour J-G, Lacoste L, Lam JYT, Waters D. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction. Am J Cardiol. 1990;66:683-688.
16. Radomski MW, Rees DD, Dutra A, Moncada S. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol. 1992;107:745-749.
17. de Belder AJ, MacAllister R, Radomski MW, Moncada S, Vallance PJT. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res. 1994;28:691-694.
18. Langford EJ, Brown AS, Wainwright RJ, de Belder AJ, Thomas MR, Smith REA, Radomski MW, Martin JF, Moncada S. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 1994;344:1458-1460.
19. Braunwald E. Unstable angina: a classification. Circulation. 1989; 80:410-414.
20. Kristensen SD, Bath PMW, Martin JF. Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina. Cardiovasc Res. 1990;24:19-23.
21. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;77:142-150.
22. Trowbridge EA, Slater DN, Kishk YT, Woodcock BW, Martin JF. Platelet production in myocardial infarction and sudden cardiac death. Thromb Haemost. 1984;52:167-171.
23. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancer. 1991;338:1409-1411.
24. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613-617.
25. Lam JYT, Latour J-G, Lesperance J, Waters D. Platelet aggregation, coronary artery disease progression and future coronary events. Am J Cardiol. 1994;73:333-338.
26. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol. 1993;22:1168-1169.
27. Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during cessation of smoking. Am J Med. 1994;97:242-249.
28. Jackson CW. Role and evaluation of megakaryocytes and platelets in cardiovascular disease: a meeting perspective. Eur J Clin Invest. 1994;24:100-104.
29. Cahill MR, Macey MG, Newland AC. Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins P-selectin (CD62) and GP53 (CD63). Br J Haematol. 1993;84:527-529.
30. Janes SL, Wilson DJ, Cox AD, Chronos NAF, Goodall AH. ADP causes partial degranulation of platelets in the absence of aggregation. Br J Haematol. 1994;86:568-573.
31. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet α-granule release. Blood. 1993;82:505-512.
32. Horstrup K, Jablonka B, Honig-Liedl P, Just M, Kochsiek K, Walter U. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser 157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem. 1994;225:21-27.
33. Fitzgerald DJ, Roy L, Robertson RM, Fitzgerald GA. The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. Circulation. 1984;70:297-302.
34. Cockcroft JR, Ritter JM. Effects of aspirin and glyceryl trinitrate on bleeding time in man. Thromb Haemorrh Disorders. 1991;3:49-51.
35. Jugdutt BI, Sussex BA, Warnica JW, Rossall RE. Persistent reduction in left ventricular asynergy in patients with acute myocardial infarction by intravenous infusion of nitroglycerin. Circulation. 1983;68:1264-1273.
36. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilator therapy. N Engl J Med. 1987;317:1055-1059.
37. Kaplan K, Davison R, Parker M, Przybylek J, Teagarden JR, Lesch M. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol. 1983;51: 694-698.
38. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988;1:1088-1092.
39. GISSI-3 (Gruppo Italiano per lo Studio della Sopravvivenza Nell'infarto Miocardico). GISSI-3: effects of lisinopril and trans-dermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115-1122.
40. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
41. Gerzer R. Karrenbrock B, Siess W, Heim J-M. Direct comparison of the effects of nitroprusside, SIN-1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb Res. 1988;52:11-21.